A Study of Baricitinib in Healthy Japanese Participants
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand the relationship of 3 different dosage forms of
baricitinib. This study will also explore the effect of food on how the body absorbs
baricitinib. This study will last about 5 weeks, not including screening. Screening is
required within 28 days prior to the date of first dosing.